Acetaminophen Completed Phase 3 Trials for Vomiting / Pain / Nausea Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT02462811A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)
NCT03657810A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg as a Treatment for Acute Pain and the Prevention of OINV